RIAS
NVO

Rachor Investment Advisory Services’s Novo Nordisk NVO Stock Holding History

Rachor Investment Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-139
Closed -$5.1K – 343
2026
Q1 		$5.1K Hold
139
– – ﹤0.01% 159
2025
Q4 		$7.06K Buy
+139
New +$7.11K ﹤0.01% 133

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Rachor Investment Advisory Services's NVO Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 139 shares — an estimated $5.1K sold.

Rachor Investment Advisory Services first reported a position in NVO in Q4 2025 and held it in 2 quarters. The position peaked at $7.06K in Q4 2025. 759 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 139 Novo Nordisk shares in Q2 2026, an estimated $5.1K.
  • Rachor Investment Advisory Services first reported a position in Novo Nordisk in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Novo Nordisk position peaked at $7.06K in Q4 2025.
  • 759 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.